While BAF alterations occur across diverse malignancies and typically in older patients, ATRT in infants and young children is most often driven by biallelic SMARCB1 loss—contrasting with the monoallelic tumor-suppressor patterns common in other cancers [29]. Here, SMARCB1 is linked to neoplasm.